Is PBMRF Stock Undervalued?

A comprehensive valuation analysis of PT Bumi Resources Tbk (PBMRF) examining current multiples, intrinsic value, and comparing to analyst expectations.

Updated April 19, 2026•8 min read•View Full Analysis

Valuation Verdict

↑

Potentially Undervalued

8993034080640.1% upside potential

Based on our analysis, PT Bumi Resources Tbk appears to be potentially undervalued at the current price of $0.01. Our fair value estimate of $1034198919.29 suggests upside potential of approximately 8993034080640.1%.

Current Valuation Metrics

Valuation ratios help us understand how the market is pricing PBMRF relative to its fundamentals. Let's examine the key multiples investors are paying today.

P/E Ratio

N/A

P/B Ratio

2.63

Moderate

P/S Ratio

15.13

High

EV/EBITDA

27.15

High

Understanding the Metrics

P/E Ratio: Not currently profitable or data unavailable.
P/B Ratio: A P/B of 2.63 means investors pay $2.63 for every $1 of book value.
P/S Ratio: The price-to-sales ratio of 15.13 indicates how much investors value each dollar of revenue.
EV/EBITDA: This ratio of 27.15 helps compare PBMRF to peers while accounting for debt.

Fair Value Estimate

Using a discounted cash flow (DCF) model, we estimate the intrinsic value of PT Bumi Resources Tbk stock. This fundamental analysis looks at the company's ability to generate future cash flows and discounts them back to today's value.

Current Price

$0.01

Fair Value Estimate

$1034198919.29

Implied Return+8993034080640.1%

Our DCF model suggests PBMRF may be undervalued by approximately 8993034080640.1%. This implies the market may be pricing in more pessimistic growth expectations than our base case scenario.

Investment Conclusion

Bottom Line

Based on our comprehensive valuation analysis, PT Bumi Resources Tbk (PBMRF) appears to be undervalued at $0.01. With a fair value estimate of $1034198919.29, the stock offers potential upside for long-term investors willing to wait for the market to recognize its intrinsic value.

Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.